TomoTherapy Incorporated, a provider of radiation therapy systems treatment of a wide variety of cancers, has signed a letter of intent with Hitachi Medical to distribute the Hi Art cancer treatment system in Japan.
Subscribe to our email newsletter
Terms of the agreement between TomoTherapy and Hitachi Medical are being finalized. Details will be announced upon contract signing. The partnership between TomoTherapy and Hitachi Medical is expected to commence by the end of 2008.
Fred Robertson, CEO of TomoTherapy, said: “We are proud to be in discussions with Hitachi Medical, a Japanese company with a national service infrastructure. Hitachi Medical should prove to be an ideal partner for TomoTherapy, and for our valued Japanese customers.”
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.